Literature DB >> 9768631

Selecting the optimum dose for a new soft gelatin capsule formulation of saquinavir. NV15107 Study Group.

J Lalezari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9768631     DOI： 10.1097/00042560-199810010-00015

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN： 1077-9450


× No keyword cloud information.
  7 in total

1.  Relationships between exposure to saquinavir monotherapy and antiviral response in HIV-positive patients.

Authors:  R Gieschke; B Fotteler; N Buss; J L Steimer
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

2.  Safety and pharmacokinetics of once-daily regimens of soft-gel capsule saquinavir plus minidose ritonavir in human immunodeficiency virus-negative adults.

Authors:  J M Kilby; G Sfakianos; N Gizzi; P Siemon-Hryczyk; E Ehrensing; C Oo; N Buss; M S Saag
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

3.  Virtual inhibitory quotient predicts response to ritonavir boosting of indinavir-based therapy in human immunodeficiency virus-infected patients with ongoing viremia.

Authors:  Nancy Shulman; Andrew Zolopa; Diane Havlir; Ann Hsu; Cheryl Renz; Sheila Boller; Ping Jiang; Richard Rode; Joel Gallant; Elizabeth Race; Dale J Kempf; Eugene Sun
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

4.  Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administration.

Authors:  N Buss; P Snell; J Bock; A Hsu; K Jorga
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

Review 5.  Saquinavir soft-gel capsule: an updated review of its use in the management of HIV infection.

Authors:  D P Figgitt; G L Plosker
Journal:  Drugs       Date:  2000-08       Impact factor: 9.546

6.  Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women.

Authors:  Edward P Acosta; Arlene Bardeguez; Carmen D Zorrilla; Russell Van Dyke; Michael D Hughes; Sharon Huang; Lisa Pompeo; Alice M Stek; Jane Pitt; D Heather Watts; Elizabeth Smith; Eleanor Jiménez; Lynne Mofenson
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

Review 7.  Saquinavir soft gelatin capsule: a comparative safety review.

Authors:  J Gill; J Feinberg
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.